These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 27758762)
21. Chromogranin A as serum marker for neuroendocrine neoplasia: comparison with neuron-specific enolase and the alpha-subunit of glycoprotein hormones. Nobels FR; Kwekkeboom DJ; Coopmans W; Schoenmakers CH; Lindemans J; De Herder WW; Krenning EP; Bouillon R; Lamberts SW J Clin Endocrinol Metab; 1997 Aug; 82(8):2622-8. PubMed ID: 9253344 [TBL] [Abstract][Full Text] [Related]
22. An Update of Neuroendocrine Tumors of the Female Reproductive System. Kefeli M; Usubütün A Turk Patoloji Derg; 2015; 31 Suppl 1():128-44. PubMed ID: 26177323 [TBL] [Abstract][Full Text] [Related]
23. Routine measurement of plasma chromogranin B has limited clinical utility in the management of patients with neuroendocrine tumours. Monaghan PJ; Lamarca A; Valle JW; Hubner RA; Mansoor W; Trainer PJ; Darby D Clin Endocrinol (Oxf); 2016 Mar; 84(3):348-52. PubMed ID: 26608723 [TBL] [Abstract][Full Text] [Related]
28. [The diagnostic value of plasma chromogranin A in neuroendocrine tumors]. Yang XO; Li JN; Qian JM; Yang H; Chen Q; Lu L Zhonghua Nei Ke Za Zhi; 2011 Feb; 50(2):124-7. PubMed ID: 21418832 [TBL] [Abstract][Full Text] [Related]
29. Diagnostic Approaches to Neuroendocrine Neoplasms of Unknown Primary Site. Berner AM; Pipinikas C; Ryan A; Dibra H; Moghul I; Webster A; Luong TV; Thirlwell C Neuroendocrinology; 2020; 110(7-8):563-573. PubMed ID: 31658461 [TBL] [Abstract][Full Text] [Related]
30. Chromogranin A in gastrinomas: Promises and pitfalls. Rehfeld JF Clin Chim Acta; 2015 Jun; 446():15-20. PubMed ID: 25861845 [TBL] [Abstract][Full Text] [Related]
31. Laboratory tests for neuroendocrine tumours. Seregni E; Ferrari L; Stivanello M; Dogliotti L Q J Nucl Med; 2000 Mar; 44(1):22-41. PubMed ID: 10932599 [TBL] [Abstract][Full Text] [Related]
32. [Treatment strategy for enteropancreatic neuroendocrine tumor]. Doi R; Tsukada T Nihon Rinsho; 2006 Jan; 64 Suppl 1():71-8. PubMed ID: 16457224 [No Abstract] [Full Text] [Related]
33. Neuroendocrine tumor biomarkers: From monoanalytes to transcripts and algorithms. Modlin IM; Bodei L; Kidd M Best Pract Res Clin Endocrinol Metab; 2016 Jan; 30(1):59-77. PubMed ID: 26971844 [TBL] [Abstract][Full Text] [Related]
34. Biochemical Testing in Patients with Neuroendocrine Tumors. Granberg D Front Horm Res; 2015; 44():24-39. PubMed ID: 26303702 [TBL] [Abstract][Full Text] [Related]
35. Limitations of Chromogranin A in clinical practice. Marotta V; Nuzzo V; Ferrara T; Zuccoli A; Masone M; Nocerino L; Del Prete M; Marciello F; Ramundo V; Lombardi G; Vitale M; Colao A; Faggiano A Biomarkers; 2012 Mar; 17(2):186-91. PubMed ID: 22303881 [TBL] [Abstract][Full Text] [Related]
36. Surgical Management of Pancreatic Neuroendocrine Tumors. Chiruvella A; Kooby DA Surg Oncol Clin N Am; 2016 Apr; 25(2):401-21. PubMed ID: 27013372 [TBL] [Abstract][Full Text] [Related]
37. [Chromogranin A: a marker of neuroendocrine tumors]. D'Herbomez M; Gouze V Ann Biol Clin (Paris); 2002; 60(6):641-6. PubMed ID: 12446227 [TBL] [Abstract][Full Text] [Related]
38. [Chromogranin A (CgA) - characteristic of the currently available laboratory methods and conditions which can influence the results]. Glinicki P; Jeske W Endokrynol Pol; 2009; 60(5):415-9. PubMed ID: 19885814 [TBL] [Abstract][Full Text] [Related]
39. Plasma chromogranin A response to octreotide test: prognostic value for clinical outcome in endocrine digestive tumors. Massironi S; Conte D; Sciola V; Spampatti MP; Ciafardini C; Valenti L; Rossi RE; Peracchi M Am J Gastroenterol; 2010 Sep; 105(9):2072-8. PubMed ID: 20372113 [TBL] [Abstract][Full Text] [Related]